» Articles » PMID: 32952350

Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement - An Uncommon But Serious Complication

Overview
Date 2020 Sep 21
PMID 32952350
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

As transcatheter aortic valve replacement (TAVR) becomes the mainstream treatment for valvular aortic stenosis, it is vitally important to recognize its associated procedural complications. Among the clinically relevant but uncommonly seen complications, the development of delayed coronary obstruction (DCO) occurring during the early post-procedural phase or even later following the index TAVR procedure, has been reported. These reports have raised concerns as TAVR comes more common in lower-risk patients. In this review article, we explored the implications of DCO for pre-procedural computed tomography evaluation, valve selection and sizing, intra-procedural manipulation, and approaches to post-procedural management.

Citing Articles

Very Late Sinus of Valsalva Sequestration After Transcatheter Aortic Valve Implantation in Native Aortic Annuli.

Ibrahim H, Chaus A, Staniloae C, Jilaihawi H, Vainrib A, Alkhalil A JACC Case Rep. 2023; 23:101992.

PMID: 37954954 PMC: 10635892. DOI: 10.1016/j.jaccas.2023.101992.

References
1.
Horsted Thyregod H, Steinbruchel D, Ihlemann N, Nissen H, Kjeldsen B, Petursson P . Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015; 65(20):2184-94. DOI: 10.1016/j.jacc.2015.03.014. View

2.
Barbosa Ribeiro H, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D . Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv. 2013; 6(5):452-61. DOI: 10.1016/j.jcin.2012.11.014. View

3.
Jatene T, Castro-Filho A, Meneguz-Moreno R, Siqueira D, Abizaid A, Ramos A . Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2016; 90(1):139-146. DOI: 10.1002/ccd.26837. View

4.
Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

5.
Tung M, Wang X, Li F, Wang H, Guo Y, Wang C . A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. J Cardiol. 2018; 72(5):377-384. DOI: 10.1016/j.jjcc.2018.05.020. View